Niklas Feilberg
Global Associate Director at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark
Niklas Feilberg’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Global Associate Director at Novo Nordisk in January 2024 - Present
Associate Director at Novo Nordisk in March 2023 - January 2024
Counsellor and Head of Health and Life Science at Udenrigsministeriet in August 2021 - March 2023
Global Product Marketing Manager at Agilent Technologies in July 2018 - July 2021
Global Sales and Marketing Specialist at Intomics A/S in June 2017 - June 2018
Patient and eHealth Partnership Lead, Associate Director at MSD in December 2016 - May 2017
Customer solutions manager (CV and Diabetes), Associate Director at MSD in May 2015 - November 2016
Commercial Manager, Therapeutic area: CV. Associate Director at MSD in January 2015 - May 2015
Patient Innovation Manager at LEO Pharma in August 2012 - February 2015
Patient Insight Manager at LEO Pharma in December 2011 - August 2012
Lean Manager at LEO Pharma in September 2009 - January 2012
Pharmacovigilance Scientist at LEO Pharma in June 2009 - December 2011
Safety Scientist at LEO Pharma in January 2008 - May 2009
Safety Assistant at LEO Pharma in May 2007 - December 2007
natural science teacher at Cirkus Naturligvis in January 2002 - December 2006
aktør Cirkus Naturligvis at Københavns Universitet in September 2002 - June 2006
Københavns Universitet - University of Copenhagen, July 2026
Københavns Universitet - University of Copenhagen, July 2026
Aurehø, July 1995 to July 1998
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Global Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Niklas Feilberg email address?
Email Niklas Feilberg at [email protected], [email protected] and [email protected]. This email is the most updated Niklas Feilberg's email found in 2026.
How to contact Niklas Feilberg?
To contact Niklas Feilberg send an email to [email protected], [email protected] or [email protected]. (updated on November 28, 2025)
What company does Niklas Feilberg work for?
Niklas Feilberg works for Novo Nordisk.
What is Niklas Feilberg's role at Novo Nordisk?
Niklas Feilberg is Global Associate Director
What industry does Niklas Feilberg work in?
Niklas Feilberg works in the Biotechnology industry.
